cp wire

CP Wire Articles

Pfizer Commences Ph Ib Trial With Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy




  • The clinical candidate, PF-06939926, consists of a recombinant AAV  Glossary Link vector expressing a miniaturized version of the DMD gene, which encodes the domains... read more
Thu, 04/12/18 - 09:22 am
Enterprise Therapeutics Raises $41 Million Series B Funding To Develop Muco-Regulatory Pipeline

  • Raises Series B round co-led by Versant Ventures and Novartis Venture Fund, with Forbion, Epidarex... read more

Thu, 04/12/18 - 08:45 am
Bellicum Shares Up After Clinical Hold lifted on BPX-501

Bellicum today announced that the U.S. Food and Drug Administration has lifted the clinical hold on studies of BPX-501 in the U.S. The decision follows consultation with the FDA and agreement on... read more

Wed, 04/11/18 - 10:32 pm
Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS


Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and CEPI – the Coalition for Epidemic Preparedness Innovations – today announced a partnership under which Inovio will develop vaccine candidates... read more

Wed, 04/11/18 - 12:16 pm
CymaBay Announces Positive Efficacy and Safety Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis

  • Seladelpar maintains potent anti-cholestatic and anti-inflammatory activity and appears safe and well tolerated, with no drug-induced pruritus, through 26 weeks of treatment
    • ... read more
Wed, 04/11/18 - 11:18 am

Pages